tiprankstipranks
Trending News
More News >

Praxis Precision Medicines Holds Annual Stockholders Meeting

Story Highlights
Praxis Precision Medicines Holds Annual Stockholders Meeting

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Praxis Precision Medicines ( (PRAX) ).

On June 26, 2025, Praxis Precision Medicines, Inc. held its Annual Meeting of Stockholders, where key decisions were made. Stockholders elected two Class II directors, ratified the appointment of Ernst & Young LLP as the independent accounting firm, and approved executive compensation on a non-binding basis. These outcomes reflect the company’s ongoing governance and operational strategies, potentially impacting its future direction and stakeholder relations.

The most recent analyst rating on (PRAX) stock is a Buy with a $114.00 price target. To see the full list of analyst forecasts on Praxis Precision Medicines stock, see the PRAX Stock Forecast page.

Spark’s Take on PRAX Stock

According to Spark, TipRanks’ AI Analyst, PRAX is a Neutral.

Praxis Precision Medicines is facing substantial financial and valuation challenges, which significantly impact its stock score. However, positive corporate developments and some technical support offer potential upside. The company’s ability to improve its financial health and successfully advance its pipeline will be crucial for future performance.

To see Spark’s full report on PRAX stock, click here.

More about Praxis Precision Medicines

Praxis Precision Medicines, Inc. operates in the pharmaceutical industry, focusing on developing treatments for central nervous system disorders. The company is involved in creating precision medicines aimed at addressing neurological conditions.

Average Trading Volume: 396,580

Technical Sentiment Signal: Sell

Current Market Cap: $882.6M

Find detailed analytics on PRAX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1